Table of Contents
What changed
Revenue rose 30.9% to NZ$223.3m and operating profit lifted 71.4% to NZ$30.6m, with PBT and NPAT each up 74.8% to NZ$29.5m and NZ$20.8m respectively. Operating cash flow grew 64.8% to NZ$35.0m and closing cash lifted to NZ$36.2m. The interim dividend was raised 33.3% to 24.0 cps. The mix shift is the most visible change: Glassons Australia grew to NZ$102.9m (46.1% of revenue, up from 42.1%) with segment pre-tax profit of NZ$19.3m, while Glassons New Zealand (27.1%) and Hallenstein Brothers (26.8%) held broadly stable shares. Inventory rose 27.3% to NZ$28.5m, broadly in line with revenue growth. Total assets increased 11.1% to NZ$201.8m and equity rose to NZ$93.3m; no gross borrowings or net debt figure was disclosed.
What matters
- Operating leverage on an Australia-led mix shift. Revenue grew 30.9% but operating profit grew 71.4%, driven by Glassons Australia delivering ~18.8% segment pre-tax margin on NZ$102.9m of revenue. This is the structural read-through: the highest-margin segment is becoming the largest, not just growing.
- Gross margin compression offset by scale. Gross margin eased 137bps to 56.5% as cost of sales grew faster than revenue. The earnings beat therefore came from operating cost absorption rather than pricing power, which matters for durability if volume growth moderates.
- Capital returns are meaningful but well covered. The 24.0 cps interim dividend represents a 68.7% payout against NPAT but only 52.8% of pre-lease FCF of NZ$27.1m, versus 90.1% NPAT payout in HY22. ROE strengthened to 22.3% from 13.7%.
Expectations
No forward guidance or stated target was included in the supplied excerpts, so run-rate commentary is limited. HY22 represented 48.6% of FY22 revenue and 46.5% of FY22 NPAT, indicating a modestly second-half-weighted historical pattern. Annualising HY23 revenue gives ~NZ$446.6m, roughly 27% above the FY22 base of NZ$351.2m; if the prior seasonality holds, implied FY23 revenue would run higher still. The release does not support stronger conclusions about H2 trading, cost trajectory, or margin direction from here.
Quality of result
The result looks operationally driven rather than timing-assisted. Tax is not a distortion (effective rate 29.5%, unchanged), there are no flagged one-offs in the excerpts, and both PBT and NPAT moved 74.8%. Operating cash flow of NZ$35.0m comfortably exceeded NPAT, and pre-lease FCF was NZ$27.1m (130.3% of NPAT, down from 152.9%). Two quality caveats: (1) capex stepped up to NZ$7.9m (3.5% of revenue vs 1.8% prior), so FCF/NPAT conversion compressed even as absolute cash generation improved; and (2) inventory at NZ$28.5m grew 27.3% — closely tracking revenue, but worth monitoring given the gross margin slip. Earnings quality is broadly credible; the mix gain from Glassons Australia is the most durable-looking driver.
Unresolved
- What drove the 137bps gross margin decline — input costs, FX, mix within Australia, or discounting?
- Why did capex more than double to NZ$7.9m, and is this a one-off fit-out cycle or a step-change run-rate?
- What is actual net debt? Total liabilities grew 14.8% to NZ$108.5m with no gross borrowings disclosure, so leverage direction cannot be quantified.
- How much of the Australia acceleration reflects new-store rollout versus like-for-like uplift, and what is sustainable?
- Is the second-half-weighted seasonality of FY22 representative, or was that pattern COVID-distorted?
This briefing cannot assess current trading, store-level economics, or any valuation multiple, as those inputs were not supplied.
Key metrics
| Metric | HY23 | HY22 | Change |
|---|---|---|---|
| Revenue | $223.3m | $170.6m | +30.9% ↑ |
| Net profit after tax | $20.8m | $11.9m | +74.8% ↑ |
| Net cash inflow from operating activities | $35.0m | $21.2m | +64.8% ↑ |
| Interim dividend per share | 24.0c | 18.0c | +33.3% ↑ |
| Operating profit | $30.6m | $17.8m | +71.4% ↑ |
| Profit before tax | $29.5m | $16.9m | +74.8% ↑ |
| Total assets | $201.8m | $181.6m | +11.1% ↑ |
Reference: annolyse.ai/briefings/hlg-hy23
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| GLASSONS NEW ZEALAND | $60.6m | $53.4m | $4.9m | -4.2pp |
| GLASSONS AUSTRALIA | $102.9m | $71.9m | $19.3m | +4.0pp |
| HALLENSTEIN BROTHERS | $59.8m | $45.3m | $5.0m | +0.3pp |
| HALLENSTEIN PROPERTY | — | — | $0.2m | n/a |
Reference: annolyse.ai/briefings/hlg-hy23
Analytical metrics
| Metric | HY23 | HY22 | Context |
|---|---|---|---|
| PBT growth | +74.8% | — | — |
| Effective tax rate | 29.5% | 29.5% | — |
| FCF pre-lease | $27.1m | $18.2m | +$8.9m |
| FCF / NPAT | 130.3% | 152.9% | complementary conversion metric |
| Capex % revenue | 3.5% | 1.8% | — |
| Capex | $7.9m | $3.0m | +$4.8m |
| Debtor days | 0.2 | 0.5 | -0.3 days |
| Inventory days | 23.2 | 23.9 | -0.7 days |
| Trade debtors | $0.2m | $0.4m | −$0.2m |
| Payout ratio vs NPAT | 68.7% | — | — |
| Payout ratio vs FCF pre-lease | 52.8% | — | covered |
| ROE (annualised) | 22.3% | 13.7% | Strengthening |
| HY22 share of FY22 revenue | 48.6% | — | Other half was 51.4% |
| HY22 share of FY22 NPAT | 46.5% | — | Other half was 53.5% |
| Profit from continuing operations | $20.8m | $11.9m | +$8.9m |
Reference: annolyse.ai/briefings/hlg-hy23
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.